Preimplantation genetic testing is a technique used to identify genetic defects in embryos created through in vitro fertilization (IVF) before pregnancy. Preimplantation genetic diagnosis (PGD) refers specifically to when one or both genetic parents has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality. In contrast, preimplantation genetic screening (PGS) refers to techniques where embryos from presumed chromosomally normal genetic parents are screened for aneuploidy. This report aims to provide a comprehensive presentation of the global market for Preimplantation Genetic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preimplantation Genetic Testing. This report contains market size and forecasts of Preimplantation Genetic Testing in global, including the following market information: Global Preimplantation Genetic Testing Market Revenue, 2018-2023, 2024-2029, ($ millions) Global top five companies in 2022 (%) The global Preimplantation Genetic Testing market was valued at US$ 356.1 million in 2022 and is projected to reach US$ 519.8 million by 2029, at a CAGR of 5.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. North America accounted for the largest share of the global preimplantation genetic testing market in 2017, followed by Europe. The large share in the North American region is mainly attributed to the rising number of IVF procedures (with decreasing fertility rates), significant adoption of genomic techniques, and the ongoing trend of replacing traditional genomic technologies with advanced and innovative genetic techniques (such as FISH and NGS). The Asia-Pacific region is expected to register the highest growth rate during the forecast period, due to the growing focus of players on emerging markets and improvements in healthcare infrastructure in these regions. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Preimplantation Genetic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Preimplantation Genetic Testing Market, by Type, 2018-2023, 2024-2029 ($ millions) Global Preimplantation Genetic Testing Market Segment Percentages, by Type, 2022 (%) Preimplantation Genetic Screening Preimplantation Genetic Diagnosis Global Preimplantation Genetic Testing Market, by Application, 2018-2023, 2024-2029 ($ millions) Global Preimplantation Genetic Testing Market Segment Percentages, by Application, 2022 (%) Maternity Centers & Fertility Clinics Hospitals, Diagnostic Labs, and Service Providers Research Laboratories & Academic Institutes Global Preimplantation Genetic Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) Global Preimplantation Genetic Testing Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Preimplantation Genetic Testing revenues in global market, 2018-2023 (estimated), ($ millions) Key companies Preimplantation Genetic Testing revenues share in global market, 2022 (%) Further, the report presents profiles of competitors in the market, key players include: Illumina Thermo Fisher Agilent Technologies Perkinelmer Coopersurgical Abbott Laboratories Natera Rubicon Genomics Oxford Gene Technology Yikon Genomics Scigene Beijing Genomics Institute Good Start Genetics Invicta Genetics Combimatrix Genea Limited Progenesis Outline of Major Chapters: Chapter 1: Introduces the definition of Preimplantation Genetic Testing, market overview. Chapter 2: Global Preimplantation Genetic Testing market size in revenue. Chapter 3: Detailed analysis of Preimplantation Genetic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Preimplantation Genetic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports 1.1 Preimplantation Genetic Testing Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Preimplantation Genetic Testing Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Researc